Citation Impact
Citing Papers
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Parkinson disease
2017 Standout
Population frequencies of inherited neuromuscular diseases—A world survey
1991 Standout
Oxidative stress, aging, and diseases
2018 Standout
Effect of atorvastatin withdrawal on circulating coenzyme Q10 concentration in patients with hypercholesterolemia
2006
Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease
2011
Targeted Disruption of the β2 Adrenergic Receptor Gene
1999 StandoutNobel
Coenzyme Q<sub>10</sub> Therapy
2014
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study
2005
Phaeochromocytoma
2005 Standout
Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs Chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2000
The muscular dystrophies
2002 Standout
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 StandoutNobel
Alcohol and Risk of Atrial Fibrillation or Flutter
2004
Phaeochromocytoma—recent progress in its management
2000
Prevalence of Muscular Dystrophies: A Systematic Literature Review
2014 Standout
Biochemical Functions of Coenzyme Q10
2001
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Metabolism and function of coenzyme Q
2003
Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension
1991 Standout
Caffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study
2005
Demographics and concomitant disorders in heart failure
2003
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
The Danish National Patient Registry: a review of content, data quality, and research potential
2015 Standout
Fish Intake, Contaminants, and Human Health
2006 Standout
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Work related physical activity and risk of a hospital discharge diagnosis of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study
2004
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Statin use and Parkinson's disease in Denmark
2010
Importance of quantitative genetic variations in the etiology of hypertension
2000 StandoutNobel
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
Coffee and Health: A Review of Recent Human Research
2006 Standout
Use of Statins and the Risk of Parkinson???s Disease
2008
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
2010 Standout
Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
2005 Standout
Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States
1997 Standout
Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA
2003
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Plasma catecholamines and essential hypertension. An analytical review.
1983
Improving compliance with therapeutic regimens in hypertensive patients in a community health center.
1979
Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee
2012 Standout
A Novel Tetracycline Labeling Schedule for Longitudinal Evaluation of the Short-Term Effects of Anabolic Therapy With a Single Iliac Crest Bone Biopsy: Early Actions of Teriparatide
2006
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Cardiovascular neural regulation explored in the frequency domain.
1991 Standout
Interventions for enhancing medication adherence
2008 Standout
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.
1993 Standout
Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension
1984
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
2003 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Interventions for enhancing medication adherence
2014 Standout
Bumetanide A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Use
1984
n−3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study1–3
2005
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Effect of High-Dose Atorvastatin on Hospitalizations for Heart Failure
2007
The electrophysiologic basis and management of symptomatic recurrent tachycardia in patients with ebstein's anomaly of the tricuspid valve
1982
Incidence of Acute Rheumatic Fever
1983
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension
2008
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Measurement of Parathyroid Hormone
1989
Nutritional Aspects of Body Water Dislocations in Postoperative and Depleted Patients
1975
Natural History of Angina Pectoris, Possible Previous Myocardial Infarction and Intermittent Claudication during the Eighth Decade
1981
Works of A Leth being referenced
Iliac crest biopsy in longitudinal therapeutic trials of osteoporosis
1988
Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors
1997
Diuretic action of bumetanide in congestive heart failure.
1975
[Priorities in the health services and population studies in Glostrup].
1980
Progressive Muscular Dystrophy in Denmark
1985
VISCERAL CHANGES IN SEVERE HYPERTENSION AND THEIR RESPONSE TO DRUG TREATMENT
1970
Plasma volume and extracellular fluid volume in essential hypertension.
1973
[Recommendations for clinical-chemical departments: lipid-lipoprotein analysis].
1990
The Prognosis in Ebstein's Disease of the Heart
1977
Changes in plasma volume and extracellular fluid volume after addition of prazosin to propranolol treatment in patients with hypertension
1978
Yersinia enterocolitica carditis as a differential diagnosis--and the prognosis of this disease.
1978
24-Hour Antihypertensive Effect of Oral Cilazapril?
1995
Elevated serum parathyroid hormone concentration during treatment with high ceiling diuretics
1980
The Distribution Volume of82Br−as a Measurement of the Extracellular Fluid Volume in Normal Persons
1970
Changes in plasma volume and extracellular fluid volume after addition of prazosin to propranolol treatment in patients with hypertension
1978
Plasma noradrenaline concentration in hypertensive and normotensive forty-year-old individuals: Relationship to plasma renin concentration
1980